AACI and NCI Issue Report on Clinical Trials Reporting Program
The Association of American Cancer Institutes (AACI), in collaboration with NCI, announced the release of the AACI-NCI Clinical Trials Reporting Program (CTRP) Strategic Subcommittee Report.
The report is the culmination of a 1-year effort to review the overall purpose of CTRP, data reporting requirements, and the CTRP implementation timeline. More information about CTRP, trial registration, patient accrual and outcomes reporting requirements, and the full report can be viewed online.
An archived videocast of the CTRP Subcommittee presentation to the NCI Clinical Trials and Translational Research Advisory Committee will be available in a few days at http://videocast.nih.gov.
Findings from two new studies show that death rates from colorectal cancer in the United States continue to fall, a trend that began more than two decades ago. The mortality decline has been geographically uneven, however, with far greater decreases in the Northeast than in many other areas, particularly in a number of southeastern states. Read more > >
The director of NCI's Center to Reduce Cancer Health Disparities welcomes colleagues to this year's Cancer Health Disparities Program Meetings Read more > >
- Advisory Panel Upholds Recommendation to Withdraw Bevacizumab Approval for Breast Cancer
- Medicare Will Cover Provenge Treatment for Prostate Cancer
- State Cancer Legislative Database Update Now Available
- Lou Staudt and Shiv Grewal Named NIH Distinguished Investigators
- NCI Cancer Classroom Webinar Series Wraps Up July 26
- Proposals Sought to Use Biospecimens from SELECT and PCPT
A MESSAGE TO READERS
Special Issue on Adolescents and Young Adults with Cancer
Don't miss our July 26 special issue, which will highlight issues that affect adolescent and young adults with cancer, as well as resources and ongoing programs that address these individuals.Past special issues have focused on bioinformatics, cancer research training, and clinical trials enrollment.
Selected articles from past issues of the NCI Cancer Bulletin are available in Spanish.
The NCI Cancer Bulletin is produced by the National Cancer Institute (NCI), which was established in 1937. Through basic, clinical, and population-based biomedical research and training, NCI conducts and supports research that will lead to a future in which we can identify the environmental and genetic causes of cancer, prevent cancer before it starts, identify cancers that do develop at the earliest stage, eliminate cancers through innovative treatment interventions, and biologically control those cancers that we cannot eliminate so they become manageable, chronic diseases.
For more information about cancer, call 1-800-4-CANCER or visit 071211.
NCI Cancer Bulletin staff can be reached at firstname.lastname@example.org.